Acute effect of sacral neuromodulation on video-urodynamic parameters of neurogenic lower urinary tract dysfunction in a patient with vesicoureteral reflux: a case report.

Neurogenic lower urinary tract dysfunction (NLUTD) is a common urological disease that causes long-term complications and severely reduces patient's quality of life. Sacral neuromodulation has proven to be an effective treatment for NLUTD. However, most previous studies have focused mainly on the efficacy and safety of sacral neuromodulation in the treatment of NLUTD and less on the changes in urodynamic parameters in patients before and after sacral neuromodulation. This study aimed to evaluate the effect of short-term sacral neuromodulation on the results of video-urodynamic parameters in a 63-year-old woman with NLUTD with vesicoureteral reflux. The patient was admitted to the Department of Urology of Beijing Hospital in January 2021 and examined using video-urodynamics. In the same month, the patient underwent the first stage of sacral neuromodulation, with an experience period of 2 weeks. After the experience period ended, video-urodynamics was performed again in February 2021. By comparing the two video-urodynamic results, the effect of short-term sacral neuromodulation on the anatomy and physiology of the lower urinary tract was determined. After 2 weeks of sacral neuromodulation treatment, video-urodynamic parameter analysis showed that while the urine storage period of the patient significantly improved, the voiding period was not significantly changed. This was specifically reflected in the improvement of bladder compliance, safe capacity of the bladder, and significant reduction in vesicoureteral reflux. The improvement of the safe capacity of the bladder effectively helped the patient to control the number of intermittent catheterizations within an acceptable range, which greatly improved her quality of life. Therefore, the patient underwent permanent sacral neuromodulation implantation in February 2021. This study suggests that short-term sacral neuromodulation can significantly improve lower urinary tract function and reduce vesicoureteral reflux in patients with NLUTD with vesicoureteral reflux. In short, we believe that sacral neuromodulation may be a good choice for patients with NLUTD.

High-grade vesicoureteral reflux in infants: Our experience with endoscopic subureteric injections.

BACKGROUND: Vesicoureteral reflux (VUR) is the most common urological anomaly in pediatric patients. Management options for VUR vary from continuous antibiotic prophylaxis (CAP) to surgery via either endoscopic subureteric injection of a bulking agent or open anti-reflux surgery. In this study, we assess the efficacy of subureteric injections of Dextranomer/Hyaluronic acid Copolymer (Deflux) in managing primary VUR in infant patients with high-grade VUR. METHODS: From 2010 to 2015, children less than 1-year-old with primary high-grade VUR were observed prospectively following the administration of endoscopic subureteric injections of Dextranomer/Hyaluronic Acid Copolymer (Deflux). The diagnosis of VUR was based on MCUG, and all patients underwent a holistic clinical, laboratory, and radiological assessment before and after the intervention. Complete success was defined as the resolution of VUR on follow up 1 year post-operatively. RESULTS: A total of 30 infants (50 renal units) with high-grade VUR (grades IV and V) were included in the study. The mean age at surgery was 6.3 ± 2.5 months. Most of the patients presented with a urinary tract infection (90%). Complete symptomatic relief was achieved in 27 patients (90%) at the first post-operative follow-up. Forty-four renal units received one injection, while six required a second injection as they did not meet our treatment success criteria. No patients required a third injection or referral for open surgery. CONCLUSION: Endoscopic injection of Dextranomer/Hyaluronic acid Copolymer (Deflux) at the vesicoureteral junction is an effective minimally invasive intervention to treat high grades VUR (IV-V) infants.

Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.

AIMS: To assess the urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux (VUR) who underwent sacral neuromodulation (SNM). METHODS: We retrospectively reviewed the records of 19 patients with neurogenic lower urinary tract dysfunction (NLUTD) who underwent SNM at our center from July 2018 to July 2019. Clinical data and video-urodynamic parameters were collected. VUR grading systems were used to evaluate upper urinary tract function. RESULTS: The mean test duration was 24 ± 8.2 days. The urodynamic evaluation showed a significant increase in the mean maximum cystometric capacity (136.3 ± 118.2 vs 216.5 ± 137.8 mL; P = .0071) and compliance (8.7 ± 8.52 vs18.3 + 16.47 mL/H2 O; P = .016), as well as a decrease in maximum intravesical pressure (57 ± 39.23 vs 36.58 ± 31.16 H2 O; P = .0064). In the voiding phase, none of the patients had automatic urination at the baseline and testing phases. In 8 of 19 patients who had detrusor overactivity (DO), the DO disappeared (four patients) or was delayed (four patients). The VUR in 3 of 12 ureter units disappeared. The grade of VUR or the volume before VUR improved in 8 ureter units, and the remaining 1 did not change significantly. An implant was performed in 16 cases. After permanent implantation, all patients needed intermittent catheterization to empty the bladder. CONCLUSIONS: This retrospective study indicates that SNM can improve the urinary storage function of the bladder in appropriate patients with NLUTD. For patients with VUR, SNM can cure or reduce VUR by improving DO and bladder compliance.

[Efficacy and safety profile of cranberry in infants and children with recurrent urinary tract infection]. / Eficacia y perfil de seguridad del arándano americano en lactantes y niños con infección urinaria recurrente.

OBJECTIVE: Cranberry prophylaxis of recurrent urinary tract infection in infants has proven effective in the experimental model of the adult. There are few data on its efficacy, safety and recommended dose in the pediatric population. METHODS: A controlled, double-blind Phase III clinical trial was conducted on children older than 1 month of age to evaluate the efficacy and safety of cranberry in recurrent urinary tract infection. The assumption was of the non-inferiority of cranberry versus trimethoprim. Statistical analysis was performed using Kaplan Meier analysis. RESULTS: A total of 85 patients under 1 year of age and 107 over 1 year were recruited. Trimethoprim was prescribed to 75 patients and 117 received cranberry. The cumulative rate of urinary infection associated with cranberry prophylaxis in children under 1 year was 46% (95% CI; 23-70) in children and 17% (95% CI; 0-38) in girls, effectively at doses inferior to trimethoprim. In children over 1 year-old cranberry was not inferior to trimethoprim, with a cumulative rate of urine infection of 26% (95% CI; 12-41). The cranberry was well tolerated and with no new adverse effects. CONCLUSIONS: Our study confirms that cranberry is safe and effective in the prophylaxis of recurrent urinary tract infection in infants and children. With the doses used, their efficiency is not less than that observed for trimethoprim among those over 1 year-old. (Clinical Trials Registry ISRCTN16968287).

Evolución de niños con anomalías del tracto urinario y propuesta de interrupción del embarazo / Progress of children with urinary tract anomalies and proposal of pregnancy cessation

Introducción: el ultrasonido diagnóstico prenatal realizado en los embarazos normales ha demostrado que por cada 500 embarazos debe aparecer una anomalía importante del tracto urinario. En diferentes situaciones puede sugerirse o recomendarse la interrupción del embarazo, que puede ser aceptado o rechazado por los padres. Objetivos: comparar el diagnóstico pre y posnatal, y valorar la evolución en 8 pacientes en los que se propuso la interrupción, pero el embarazo continuó. Resultados: en 6 de los fetos se propuso la interrupción por el diagnóstico de hidronefrosis bilateral; en uno, por quistes renales bilaterales, y en otro por hidronefrosis unilateral y displasia renal multiquística contralateral. En 2 recién nacidos hubo coincidencia total entre el diagnóstico prenatal y el posnatal, en uno con reflujo de alto grado se encontró ureterohidronefrosis bilateral en el estudio prenatal, mientras que en 2 solamente hidronefrosis; un paciente tiene megauréter bilateral no obstructivo, y otro pielectasia bilateral. En el feto que se plantearon los quistes renales bilaterales, el estudio posnatal mostró un doble sistema excretor derecho con el superior obstruido, y reflujo vesicoureteral grado III del inferior con riñón izquierdo normal. Durante el tiempo de seguimiento la conducta médica varió de acuerdo con el diagnóstico posnatal. Al concluir el período de seguimiento, un paciente tiene una enfermedad renal crónica etapa 3, y los 7 restantes tienen función renal conservada. Conclusiones: la indicación de interrupción del embarazo por el diagnóstico ultrasonográfico prenatal de una anomalía renal o de tracto urinario tiene un margen de error que es necesario seguir estudiando y buscar indicadores de alto riesgo vital, porque los factores predictivos no están bien precisados(AU)

Introduction: prenatal ultrasound diagnosis performed in normal pregnancies has shown that one significant urinary tract anomaly occurs per 500 pregnancies. Under different circumstances, termination of pregnancy may be suggested or recommended, which may be accepted or rejected by parents. Objectives: to compare the pre-and postnatal diagnoses, and to assess the progress in 8 patients who were recommended to terminate their pregnancies, but they rejected this idea. Results: in 6 cases, the termination of pregnancy was suggested on account of bilateral hydronephrosis diagnosis in their fetuses; in one case due to bilateral renal cysts diagnosis and in the other case due to unilateral hydronephrosis and contralateral multicystic renal dysplasia. There was full agreement between the prenatal and postnatal diagnoses in 2 newborns; in a neonate with high grade reflux, the prenatal study revealed bilateral ureterohydronephrosis whereas this study showed just hydronephrosis for other two fetuses. One patient has non-obstructive bilateral megaureter and the other presents bilateral pyelectasy. The fetus with bilateral renal cysts presented, according to the postnatal study, a double right excretory system, being the upper obstructed and the lower with grade III vesicoureteral reflux, but his left kidney was normal. In the follow-up period, the medical behavior varied according to the postnatal diagnoses. Upon finishing this period, one patient had phase III chronic renal disease and the other seven had preserved renal function. Conclusions: the indication of termination of pregnancy based on the prenatal ultrasonographic diagnosis of a renal or urinary tract anomaly has an error index that must be further studied, and it is necessary to look for high life risk indicators because the predictive factors are not well detailed(AU)

Evolución de niños con anomalías del tracto urinario y propuesta de interrupción del embarazo / Progress of children with urinary tract anomalies and proposal of pregnancy cessation

Introducción: el ultrasonido diagnóstico prenatal realizado en los embarazos normales ha demostrado que por cada 500 embarazos debe aparecer una anomalía importante del tracto urinario. En diferentes situaciones puede sugerirse o recomendarse la interrupción del embarazo, que puede ser aceptado o rechazado por los padres. Objetivos: comparar el diagnóstico pre y posnatal, y valorar la evolución en 8 pacientes en los que se propuso la interrupción, pero el embarazo continuó. Resultados: en 6 de los fetos se propuso la interrupción por el diagnóstico de hidronefrosis bilateral; en uno, por quistes renales bilaterales, y en otro por hidronefrosis unilateral y displasia renal multiquística contralateral. En 2 recién nacidos hubo coincidencia total entre el diagnóstico prenatal y el posnatal, en uno con reflujo de alto grado se encontró ureterohidronefrosis bilateral en el estudio prenatal, mientras que en 2 solamente hidronefrosis; un paciente tiene megauréter bilateral no obstructivo, y otro pielectasia bilateral. En el feto que se plantearon los quistes renales bilaterales, el estudio posnatal mostró un doble sistema excretor derecho con el superior obstruido, y reflujo vesicoureteral grado III del inferior con riñón izquierdo normal. Durante el tiempo de seguimiento la conducta médica varió de acuerdo con el diagnóstico posnatal. Al concluir el período de seguimiento, un paciente tiene una enfermedad renal crónica etapa 3, y los 7 restantes tienen función renal conservada. Conclusiones: la indicación de interrupción del embarazo por el diagnóstico ultrasonográfico prenatal de una anomalía renal o de tracto urinario tiene un margen de error que es necesario seguir estudiando y buscar indicadores de alto riesgo vital, porque los factores predictivos no están bien precisados

Introduction: prenatal ultrasound diagnosis performed in normal pregnancies has shown that one significant urinary tract anomaly occurs per 500 pregnancies. Under different circumstances, termination of pregnancy may be suggested or recommended, which may be accepted or rejected by parents. Objectives: to compare the pre-and postnatal diagnoses, and to assess the progress in 8 patients who were recommended to terminate their pregnancies, but they rejected this idea. Results: in 6 cases, the termination of pregnancy was suggested on account of bilateral hydronephrosis diagnosis in their fetuses; in one case due to bilateral renal cysts diagnosis and in the other case due to unilateral hydronephrosis and contralateral multicystic renal dysplasia. There was full agreement between the prenatal and postnatal diagnoses in 2 newborns; in a neonate with high grade reflux, the prenatal study revealed bilateral ureterohydronephrosis whereas this study showed just hydronephrosis for other two fetuses. One patient has non-obstructive bilateral megaureter and the other presents bilateral pyelectasy. The fetus with bilateral renal cysts presented, according to the postnatal study, a double right excretory system, being the upper obstructed and the lower with grade III vesicoureteral reflux, but his left kidney was normal. In the follow-up period, the medical behavior varied according to the postnatal diagnoses. Upon finishing this period, one patient had phase III chronic renal disease and the other seven had preserved renal function. Conclusions: the indication of termination of pregnancy based on the prenatal ultrasonographic diagnosis of a renal or urinary tract anomaly has an error index that must be further studied, and it is necessary to look for high life risk indicators because the predictive factors are not well detailed

Transient Pseudohypoaldosteronism in an Infant with Vesicoureteral Reflux

A 6-month-old boy with vesicoureteral reflux exhibited features of transient type 1 pseudohypoaldosteronism (PHA) in the course of urinary tract infection. PHA presents hyponatremia, hyperkalemia, and metabolic acidosis, accompanying with high urinary sodium, low potassium excretion, and high plasma aldosterone concentration. Severe electrolyte disturbance can occur in an infant with vesicoureteral reflux because of secondary PHA. Appropriate treatment of dehydration and sodium supplementation induces rapid improvement of electrolyte imbalance and metabolic acidosis resulting from secondary PHA associated with vesicoureteral reflux.